Do phosphodiesterase type 5 inhibitors protect against condom-associated erection loss and condom slippage?
Introduction.? Some physicians prescribe phosphodiesterase type 5 inhibitors (PDE5i) for men who experience condom-associated erection difficulties with a view to increasing condom use and reducing risk of sexually transmitted infections. Aim.? To examine whether the prevalence of erection-related...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2009.
|
Subjects: | |
Online Access: | Get fulltext |